AFTER MORE THAN 40 YEARS OF NMIBC TREATMENT, LITTLE HAS EVOLVED BUT OUR DESIRE TO DO MORE1
Although significant progress has been made in treating many tumor types, outcomes for patients with NMIBC (non–muscle-invasive bladder cancer) have remained stagnant for decades.1 It’s time to look closely at where we stand with bladder cancer.
I'm currently undergoing BCG treatments. I'm glad I have this option before thinking about cystectomy, but there are challenges.
I wasn’t always able to get my BCG treatment or I would get less than I was supposed to because of shortages. I worry that my cancer will get worse.
My cancer recurred after completing all of my BCG treatments. Now my urologist is recommending cystectomy, but I'm struggling with this decision.
Reference:
Cancer stat facts: bladder cancer. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Accessed February 13, 2024. https://seer.cancer.gov/statfacts/html/urinb.html
